Pancracine, a montanine-type Amaryllidaceae alkaloid (AA), is one of the most potent compounds among natural isoquinolines. In previous studies, pancracine exhibited cytotoxic activity against diverse human cancer cell lines in vitro. However, further insight into the molecular mechanisms that underlie the cytotoxic effect of pancracine have not been reported and remain unknown. To fill this void, the cell proliferation and viability of cancer cells was explored using the Trypan Blue assay or by using the xCELLigence system. The impact on the cell cycle was determined by flow cytometry. Apoptosis was evaluated by Annexin V/PI and by quantifying the activity of caspases (-3/7, -8, and -9). Proteins triggering growth arrest or apoptosis were detected by Western blotting. Pancracine has strong antiproliferative activity on A549 cells, lasting up to 96 h, and antiproliferative and cytotoxic effects on MOLT-4 cells. The apoptosis-inducing activity of pancracine in MOLT-4 cells was evidenced by the significantly higher activity of caspases. This was transmitted through the upregulation of p53 phosphorylated on Ser392, p38 MAPK phosphorylated on Thr180/Tyr182, and upregulation of p27. The pancracine treatment negatively altered the proliferation of A549 cells as a consequence of an increase in G1-phase accumulation, associated with the downregulation of Rb phosphorylated on Ser807/811 and with the concomitant upregulation of p27 and downregulation of Akt phosphorylated on Thr308. This was the first study to glean a deeper mechanistic understanding of pancracine activity in vitro. Perturbation of the cell cycle and induction of apoptotic cell death were considered key mechanisms of pancracine action.

ADINACO Research Group Department of Pharmaceutical Botany Faculty of Pharmacy Charles University Heyrovskeho 1203 500 05 Hradec Kralove Czech Republic

Department of Biological and Biochemical Sciences Faculty of Chemical Technology University of Pardubice Studentska 573 532 10 Pardubice Czech Republic

Department of Medical Biochemistry Faculty of Medicine in Hradec Kralove Charles University Simkova 870 500 03 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75:311–335. doi: 10.1021/np200906s. PubMed DOI PMC

Desgagné-Penix I. Biosynthesis of alkaloids in Amaryllidaceae plants: A review. Phytochem. Rev. 2021;20:409–431. doi: 10.1007/s11101-020-09678-5. DOI

Cahlíková L., Kawano I., Řezáčová M., Blunden G., Hulcová D., Havelek R. The Amaryllidaceae alkaloids haemanthamine, haemanthidine and their semisynthetic derivatives as potential drugs. Phytochem. Rev. 2021;20:303–323. doi: 10.1007/s11101-020-09675-8. DOI

Wildman W.C., Brown C.L. Mass spectra of 5,11-methanomorphanthridine alkaloids. The structure of pancracine. J. Am. Chem. Soc. 1968;90:6439–6446. doi: 10.1021/ja01025a036. PubMed DOI

Govindaraju K., Ingels A., Hasan M.N., Sun D., Mathieu V., Masi M., Evidente A., Kornienko A. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells. Bioorg. Med. Chem. Lett. 2018;28:589–593. doi: 10.1016/j.bmcl.2018.01.041. PubMed DOI PMC

Breiterová K., Koutová D., Maríková J., Havelek R., Kuneš J., Majorošová M., Opletal L., Hošt’álková A., Jenco J., Rezáčová M., et al. Amaryllidaceae alkaloids of different structural types from Narcissus L. cv. Professor Einstein and their cytotoxic activity. Plants. 2020;9:137. doi: 10.3390/plants9020137. PubMed DOI PMC

Wildman W.C., Kaufman C.J. Alkaloids of the Amaryllidaceae. III. Isolation of five new alkaloids from Haemanthus species1. J. Am. Chem. Soc. 1955;77:1248–1252. doi: 10.1021/ja01610a045. DOI

Koutová D., Maafi N., Havelek R., Opletal L., Blunden G., Řezáčová M., Cahlíková L. Chemical and biological aspects of montanine-type alkaloids isolated from plants of the Amaryllidaceae family. Molecules. 2020;25:2337. doi: 10.3390/molecules25102337. PubMed DOI PMC

Cedrón J.C., Ravelo A.G., León L.G., Padrón J.M., Estévez-Braun A. Antiproliferative and structure activity relationships of Amaryllidaceae alkaloids. Molecules. 2015;20:13854–13863. doi: 10.3390/molecules200813854. PubMed DOI PMC

Masi M., van Slambrouck S., Gunawardana S., van Rensburg M.J., James P.C., Mochel J.G., Heliso P.S., Albalawi A.S., Cimmino A., van Otterlo W.A.L., et al. Alkaloids isolated from Haemanthus humilis Jacq., an indigenous South African Amaryllidaceae: Anticancer activity of coccinine and montanine. S. Afr. J. Bot. 2019;126:277–281. doi: 10.1016/j.sajb.2019.01.036. DOI

Evidente A., Andolfi A., Abou-Donia A.H., Touema S.M., Hammoda H.M., Shawky E., Motta A. (−)-Amarbellisine, a lycorine-type alkaloid from Amaryllis belladonna L. growing in Egypt. Phytochemistry. 2004;65:2113–2118. doi: 10.1016/j.phytochem.2004.03.020. PubMed DOI

Labraña J., Machocho A.K., Kricsfalusy V., Brun R., Codina C., Viladomat F., Bastida J. Alkaloids from Narcissus angustifolius subsp. transcarpathicus. Phytochemistry. 2002;60:847–852. doi: 10.1016/S0031-9422(02)00154-1. PubMed DOI

Habartová K., Cahlíková L., Řezáčová M., Havelek R. The biological activity of alkaloids from the Amaryllidaceae: From cholinesterases inhibition to anticancer activity. Nat. Prod. Commun. 2016;11:1587–1594. doi: 10.1177/1934578X1601101038. PubMed DOI

Havelek R., Seifrtová M., Královec K., Bručková L., Cahlíková L., Dalecká M., Vávrová J., Řezáčová M., Opletal L., Bílková Z. The effect of Amaryllidaceae alkaloids Haemanthamine and Haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells. Phytomedicine. 2014;21:479–490. doi: 10.1016/j.phymed.2013.09.005. PubMed DOI

Guan Y., Zhang H., Pan C., Wang J., Huang R., Li Q. Flexible synthesis of montanine-like alkaloids: Revisiting the structure of montabuphine. Org. Biomol. Chem. 2012;10:3812–3814. doi: 10.1039/c2ob25374g. PubMed DOI

Matveenko M., Banwell M.G., Willis A.C. A chemoenzymatic total synthesis of the structure assigned to the alkaloid (+)-montabuphine. Org. Lett. 2008;10:4693–4696. doi: 10.1021/ol801815k. PubMed DOI

Ishizaki M., Hoshino O., Iitaka Y. Total synthesis of montanine-type Amaryllidaceae alkaloids, which possess a 5, 11-methanomorphanthridine ring system, through cyclization with sodium bis (2-methoxyethoxy) aluminum hydride (SMEAH): The first stereoselective total syntheses of (±)-montanine, (±)-coccinine, (±)-O-acetylmontanine, (±)-pancracine, and (±)-brunsvigine. J. Org. Chem. 1992;57:7285–7295.

Bao X., Cao Y.X., Chu W.D., Qu H., Du J.Y., Zhao X.H., Ma X.Y., Wang C.T., Fan C.A. Bioinspired total synthesis of montanine-type Amaryllidaceae alkaloids. Angew. Chem. Int. Edit. 2013;52:14167–14172. doi: 10.1002/anie.201307324. PubMed DOI

Hong A.W., Cheng T.H., Raghukumar V., Sha C.K. An expedient route to montanine-type Amaryllidaceae alkaloids: Total syntheses of (−)-brunsvigine and (−)-manthine. J. Org. Chem. 2008;73:7580–7585. doi: 10.1021/jo801089y. PubMed DOI

Pandey G., Gadre S.R. Stereoselective construction of 5,11-methanomorphanthridine and 5,10b-phenanthridine structural frameworks: Total syntheses of (±)-pancracine, (±)-brunsvigine, (±)-maritidine, and (±)-crinine. Pure Appl. Chem. 2012;84:1597–1619. doi: 10.1351/PAC-CON-11-10-12. DOI

Inubushi Y., Fales H.M., Warnhoff E.W., Wildman W.C. Structures of montanine, coccinine, and manthine. J. Org. Chem. 1960;25:2153–2164. doi: 10.1021/jo01082a019. DOI

Cedrón J.C., Estévez-Braun A., Ravelo A., Gutiérrez D., Flores N., Bucio M.A., Pérez-Hernández N., Joseph-Nathan P. Bioactive montanine derivatives from halide-induced rearrangements of haemanthamine-type alkaloids. Absolute configuration by VCD. Org. Lett. 2009;11:1491–1494. doi: 10.1021/ol900065x. PubMed DOI

Al Shammari L., Al Mamun A., Koutová D., Majorošová M., Hulcová D., Šafratová M., Breiterová K., Maříková J., Havelek R., Cahlíková L. Alkaloid profiling of Hippeastrum cultivars by GC-MS, isolation of Amaryllidaceae alkaloids and evaluation of their cytotoxicity. Rec. Nat. Prod. 2020;14:154–159. doi: 10.25135/rnp.147.19.06.1302. DOI

Ambrosino C., Nebreda A.R. Cell cycle regulation by p38 MAP kinases. Biol. Cell. 2001;93:47–51. doi: 10.1016/S0248-4900(01)01124-8. PubMed DOI

Abbastabar M., Kheyrollah M., Azizian K., Bagherlou N., Tehrani S.S., Maniati M., Karimian A. Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein. DNA Repair. 2018;69:63–72. doi: 10.1016/j.dnarep.2018.07.008. PubMed DOI

Šalovská B., Janečková H., Fabrik I., Karlíková R., Čecháková L., Ondrej M., Link M., Friedecký D., Tichý A. Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells. PLoS ONE. 2018;13:e0199349. doi: 10.1371/journal.pone.0199349. PubMed DOI PMC

Tichý A., Záškodová D., Pejchal J., Řezáčová M., Österreicher J., Vávrová J., Cerman J. Gamma irradiation of human leukaemic cells HL-60 and MOLT-4 induces decrease in Mcl-1 and Bid, release of cytochrome c, and activation of caspase-8 and caspase-9. Int. J. Radiat. Biol. 2008;84:523–530. doi: 10.1080/09553000802078404. PubMed DOI

Muthna D., Vavrova J., Lukasova E., Tichy A., Knizek J., Kohlerova R., Mazankova N., Rezacova M. Valproic acid decreases the reparation capacity of irradiated MOLT-4 cells. Mol. Biol. 2012;46:110–116. doi: 10.1134/S0026893312010141. PubMed DOI

Řezáčová M., Tichý A., Vávrová J., Vokurková D., Lukášová E. Is defect in phosphorylation of Nbs1 responsible for high radiosensitivity of T-lymphocyte leukemia cells MOLT-4? Leuk. Res. 2008;32:1259–1267. doi: 10.1016/j.leukres.2007.12.014. PubMed DOI

Pellegrino S., Meyer M., Zorbas C., Bouchta S.A., Saraf K., Pelly S.C., Yusupova G., Evidente A., Mathieu V., Kornienko A., et al. The Amaryllidaceae alkaloid haemanthamine binds the eukaryotic ribosome to repress cancer cell growth. Structure. 2018;26:416–425. doi: 10.1016/j.str.2018.01.009. PubMed DOI